Nectin 4 is the epithelial cell receptor for measles virus

Trends in Microbiology

Volumn 20, Issue 9, 2012, Pages 429-439

  Noyce, Ryan S ^a,b   Richardson, Christopher D ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Canadian Center for Vaccinology Dalhousie University Halifax   (Canada)

Author keywords

Adenocarcinoma; Adherens junctions; Epithelial receptor; Measles; Nectin 4; Oncolytic virus; PVRL4; Virus release

Indexed keywords

CANCER VACCINE; CD150 ANTIGEN; CELL RECEPTOR; MEMBRANE COFACTOR PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN; NECTIN 1; NECTIN 4; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CELL JUNCTION; DISEASE PREDISPOSITION; EPITHELIUM CELL; GENE OVEREXPRESSION; HUMAN; LUNG CANCER; MEASLES; MEASLES VIRUS; NONHUMAN; ONCOLYTIC VIROTHERAPY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RESPIRATORY EPITHELIUM; REVIEW; UPREGULATION; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS STRAIN; VIRUS VIRULENCE;

MACACA; MEASLES VIRUS;

EID: 84865774023     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2012.05.006     Document Type: Review

References (84)

1. Oldstone M.B.A. Viruses, Plagues, and History: Past, Present, and Future 2010, Oxford University Press.
2. Griffin D.E. Measles Virus. Fields' Virology 2006, 1551-1585. Lippincott, Williams, and Wilkins. D.M.H. Knipe (Ed.).
3. Griffin D.E., Oldstone M.B. Measles. History and basic biology. Introduction. Curr. Top. Microbiol. Immunol. 2009, 329:1.
4. Griffin D.E., Oldstone M.M. Measles. Pathogenesis and control. Introduction. Curr. Top. Microbiol. Immunol. 2009, 330:1.
5. Moss W.J., Griffin D.E. Measles. Lancet 2012, 379:153-164.
6. Oldstone M.B. Modeling subacute sclerosing panencephalitis in a transgenic mouse system: uncoding pathogenesis of disease and illuminating components of immune control. Curr. Top. Microbiol. Immunol. 2009, 330:31-54.
7. Young V.A., Rall G.F. Making it to the synapse: measles virus spread in and among neurons. Curr. Top. Microbiol. Immunol. 2009, 330:3-30.
8. Yanagi Y., et al. Measles virus receptors. Curr. Top. Microbiol. Immunol. 2009, 329:13-30.
9. Dorig R.E., et al. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993, 75:295-305.
10. Naniche D., et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 1993, 67:6025-6032.
11. Kemper C., Atkinson J.P. Measles virus and CD46. Curr. Top. Microbiol. Immunol. 2009, 329:31-57.
12. Hsu E.C., et al. A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J. Virol. 1998, 72:2905-2916.
13. Lecouturier V., et al. Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J. Virol. 1996, 70:4200-4204.
14. Tahara M., et al. Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently. J. Virol. 2007, 81:2564-2572.
15. Kobune F., et al. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 1990, 64:700-705.
16. Shibahara K., et al. Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures. J. Gen. Virol. 1994, 75:3511-3516.
17. Bartz R., et al. Differential receptor usage by measles virus strains. J. Gen. Virol. 1998, 79:1015-1025.
18. Buckland R., Wild T.F. Is CD46 the cellular receptor for measles virus?. Virus Res. 1997, 48:1-9.
19. Tatsuo H., et al. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000, 406:893-897.
20. Erlenhoefer C., et al. CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J. Virol. 2001, 75:4499-4505.
21. Hsu E.C., et al. CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology 2001, 279:9-21.
22. Schwartzberg P.L., et al. SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat. Rev. Immunol. 2009, 9:39-46.
23. Hashiguchi T., et al. Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat. Struct. Mol. Biol. 2011, 18:135-141.
24. Santiago C., et al. Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat. Struct. Mol. Biol. 2010, 17:124-129.
25. Navaratnarajah C.K., et al. Measles virus glycoprotein complex assembly, receptor attachment, and cell entry. Curr. Top. Microbiol. Immunol. 2009, 329:59-76.
26. Navaratnarajah C.K., et al. The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat. Struct. Mol. Biol. 2011, 18:128-134.
27. de Witte L., et al. Measles virus targets DC-SIGN to enhance dendritic cell infection. J. Virol. 2006, 80:3477-3486.
28. + T cells but are incapable of cross-presentation. Eur. J. Immunol. 2011, 41:2619-2631.
29. Santiago C., et al. Distinct kinetics for binding of the CD46 and SLAM receptors to overlapping sites in the measles virus hemagglutinin protein. J. Biol. Chem. 2002, 277:32294-32301.
30. Ono N., et al. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J. Virol. 2001, 75:4399-4401.
31. Hashimoto K., et al. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J. Virol. 2002, 76:6743-6749.
32. Takeuchi K., et al. Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism. Virus Res. 2003, 94:11-16.
33. Leonard V.H., et al. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J. Clin. Invest. 2008, 118:2448-2458.
34. Ludlow M., et al. Wild-type measles virus infection of primary epithelial cells occurs via the basolateral surface without syncytium formation or release of infectious virus. J. Gen. Virol. 2009, 91:971-979.
35. Shirogane Y., et al. Epithelial-mesenchymal transition abolishes the susceptibility of polarized epithelial cell lines to measles virus. J. Biol. Chem. 2010, 285:20882-20890.
36. Tahara M., et al. Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J. Virol. 2008, 82:4630-4637.
37. Takeda M., et al. A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism. J. Virol. 2007, 81:12091-12096.
38. Noyce R.S., et al. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog. 2011, 7:e1002240.
39. Takeda M., et al. Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 2000, 74:6643-6647.
40. Muhlebach M.D., et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011, 480:530-533.
41. Ogita H., et al. Cell adhesion molecules nectins and associating proteins: implications for physiology and pathology. Proc. Jpn. Acad. Ser. B: Phys. Biol. Sci. 2010, 86:621-629.
42. Brancati F., et al. Mutations in PVRL4, encoding cell adhesion molecule nectin-4, cause ectodermal dysplasia-syndactyly syndrome. Am. J. Hum. Genet. 2010, 87:265-273.
43. Meng W., Takeichi M. Adherens junction: molecular architecture and regulation. Cold Spring Harb. Perspect. Biol. 2009, 1:a002899.
44. Reymond N., et al. Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction. J. Biol. Chem. 2001, 276:43205-43215.
45. Mendelsohn C.L., et al. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989, 56:855-865.
46. Geraghty R.J., et al. Entry of alphaherpesviruses mediated by poliovirus receptor- related protein 1 and poliovirus receptor. Science 1998, 280:1618-1620.
47. Lopez M., et al. Nectin2alpha (PRR2alpha or HveB) and nectin2delta are low- efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D. J. Virol. 2000, 74:1267-1274.
48. Albrecht P., et al. Fatal measles infection in marmosets pathogenesis and prophylaxis. Infect. Immun. 1980, 27:969-978.
49. Kobune F., et al. Nonhuman primate models of measles. Lab. Anim. Sci. 1996, 46:315-320.
50. de Swart R.L. Measles studies in the macaque model. Curr. Top. Microbiol. Immunol. 2009, 330:55-72.
51. Blake F.G., Trask J.D. Studies on measles. I. Susceptibility of monkeys to the virus of measles. J. Exp. Med. 1921, 33:385-412.
52. de Witte L., et al. DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS Pathog. 2008, 4:e1000049.
53. de Swart R.L. The pathogenesis of measles revisited. Pediatr. Infect. Dis. J. 2008, 27:S84-S88.
54. + lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog. 2007, 3:e178.
55. Lemon K., et al. Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog. 2010, 7:e1001263.
56. Sellin C.I., Horvat B. Current animal models: transgenic animal models for the study of measles pathogenesis. Curr. Top. Microbiol. Immunol. 2009, 330:111-127.
57. Ferreira C.S., et al. Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150). J. Virol. 2009, 84:3033-3042.
58. Ohno S., et al. Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection. J. Virol. 2007, 81:1650-1659.
59. Welstead G.G., et al. Measles virus replication in lymphatic cells and organs of CD150 (SLAM) transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:16415-16420.
60. Niewiesk S. Current animal models: cotton rat animal model. Curr. Top. Microbiol. Immunol. 2009, 330:89-110.
61. Pillet S., von Messling V. Canine distemper virus selectively inhibits apoptosis progression in infected immune cells. J. Virol. 2009, 83:6279-6287.
62. Sawatsky B., et al. Canine distemper virus epithelial cell infection is required for clinical disease but not for immunosuppression. J. Virol. 2012, 86:3658-3666.
63. von Messling V., et al. Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:14216-14221.
64. Kubo A., et al. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J. Exp.Med. 2009, 206:2937-2946.
65. Nagai S., et al. Role of Peyer's patches in the induction of Helicobacter pylori- induced gastritis. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:8971-8976.
66. Avota E., et al. DC-SIGN mediated sphingomyelinase-activation and ceramide generation is essential for enhancement of viral uptake in dendritic cells. PLoS Pathog. 2011, 7:e1001290.
67. Pabst R., Tschernig T. Bronchus-associated lymphoid tissue: an entry site for antigens for successful mucosal vaccinations?. Am. J. Respir. Cell Mol. Biol. 2010, 43:137-141.
68. Racaniello V. Virology. An exit strategy for measles virus. Science 2011, 334:1650-1651.
69. Derycke M.S., et al. Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker. Am. J. Clin. Pathol. 2010, 134:835-845.
70. Fabre-Lafay S., et al. Nectin-4 is a new histological and serological tumor associated marker for breast cancer. BMC Cancer 2007, 7:73.
71. Takano A., et al. Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer. Cancer Res. 2009, 69:6694-6703.
72. Bluming A.Z., Ziegler J.L. Regression of Burkitt's lymphoma in association with measles infection. Lancet 1971, 2:105-106.
73. Mota H.C. Infantile Hodgkin's disease: remission after measles. Br. Med. J. 1973, 2:421.
74. Taqi A.M., et al. Regression of Hodgkin's disease after measles. Lancet 1981, 1:1112.
75. Zygiert Z. Hodgkin's disease: remissions after measles. Lancet 1971, 1:593.
76. Russell S.J., Peng K.W. Measles virus for cancer therapy. Curr. Top. Microbiol. Immunol. 2009, 330:213-241.
77. Li H., et al. Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapy. Hum. Gene Ther. 2012, 23:295-301.
78. Iankov I.D., et al. Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus. Mol. Ther. 2012, 20:1139-1147.
79. Lech P.J., Russell S.J. Use of attenuated paramyxoviruses for cancer therapy. Expert Rev. Vaccines 2010, 9:1275-1302.
80. Makhortova N.R., et al. Neurokinin-1 enables measles virus trans-synaptic spread in neurons. Virology 2007, 362:235-244.
81. Andres O., et al. CD46- and CD150-independent endothelial cell infection with wild-type measles viruses. J. Gen. Virol. 2003, 84:1189-1197.
82. + hematopoietic progenitor cells. J. Virol. 2011, 85:7710-7718.
83. + cells by measles virus. J. Virol. 2002, 76:6636-6642.
84. Tayyari F., et al. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 2011, 17:1132-1135.